Market Size of Biomaterial Wound Dressing Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 11.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Biomaterial Wound Dressing Market Analysis
The biomaterial wound dressing market is expected to register a CAGR of 11.2% during the forecast period.
The COVID-19 pandemic severely affected the healthcare sector, including the biomaterial wound dressing segment. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals globally. For instance, according to an article published by the AJMC in September 2021, a significant percentage of patients with chronic wounds had delayed preventative and emergent wound care during the COVID-19 pandemic. Such delays during the COVID-19 pandemic negatively impacted the growth of the studied market. However, with the restrictions being lifted, wound care services have been resumed, which is expected to add to the growth of the biomaterial wound dressing market over the forecast period.
The biomaterial wound dressing market is driven by advancements in technology, a growing ageing population, the rising burden of chronic wounds and problems, and side effects associated with conventional wound healing procedures. Furthermore, an increase in government initiatives, demand for fast and safe treatment for chronic wounds, and an increase in the prevalence of lifestyle disorders such as diabetes leading to venous leg ulcers, pressure ulcers, and diabetic foot ulcers propels the growth of the market. For instance, according to the International Diabetes Federation's IDF Diabetes Atlas Tenth edition 2021, over 537 million adults in the world were living with diabetes in the year 2021. The source also reported that the number of diabetic people in the world would increase to 643 million by 2030 and 783 million by 2045. The rising number of people affected by diabetes, who are more susceptible to foot ulcers is expected to boost the growth of the studied market.
The expansion of public health programs devoted to wound management is also anticipated to fuel market expansion. During a webinar hosted by the National Wound Care Strategy Programme in May 2022, for instance, presenters discussed a number of different approaches to healing venous leg ulcers. The expansion of the examined market is anticipated to benefit from initiatives aimed at raising public awareness of wound care services.
However, the high cost of treatment and unfavorable reimbursement policies are the few factors that hinder the market growth.
Biomaterial Wound Dressing Industry Segmentation
As per the scope of the report, the wound is a disruption of skin epithelial lining or mucosa which results in thermal or physical damage. Any biomaterial wound dressing is a substance that has been engineered to interact with biological systems for controlling and healing infections. The biomaterial wound dressing market is segmented by product (hydrocolloids, alginate dressing, skin substitutes, others), application (wounds, burns, ulcers, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | |
| Hydrocolloids | |
| Alginate Dressing | |
| Skin Substitutes | |
| Other Products |
| By Application | |
| Wounds | |
| Burns | |
| Ulcers | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Biomaterial Wound Dressing Market Size Summary
The biomaterial wound dressing market is poised for significant growth, driven by technological advancements and an increasing aging population. The market's expansion is further supported by the rising prevalence of chronic wounds and the limitations of conventional wound healing methods. Government initiatives and the demand for rapid, effective treatments for chronic wounds, particularly those related to lifestyle disorders like diabetes, are also contributing to market growth. The COVID-19 pandemic initially hindered market progress by delaying wound care services, but the resumption of these services is expected to bolster the market. Public health programs focused on wound management and increased awareness of wound care services are anticipated to further fuel market expansion. However, challenges such as high treatment costs and unfavorable reimbursement policies may impede growth.
In North America, the biomaterial wound dressing market is expected to hold a substantial share globally, driven by a rapidly growing aging population and a high prevalence of diabetes. The region's developed healthcare system, which is quick to adopt novel innovations, supports this growth. The presence of key market players and their focus on research and development, along with the introduction of advanced products, are expected to enhance market dynamics. Alginate dressings, known for their hydrophilic properties and wide application in treating various types of wounds, are anticipated to see increased demand. The market is moderately fragmented, with major players like 3M, ConvaTec Group PLC, and Smith & Nephew PLC holding significant shares and actively pursuing product innovation to capture a larger market segment.
Biomaterial Wound Dressing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Chronic Wounds and Associated Diseases
-
1.2.2 Government Initiatives Regarding Wound Care Treatment
-
-
1.3 Market Restraints
-
1.3.1 Lack of Proper Reimbursement
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
2.1 By Product
-
2.1.1 Hydrocolloids
-
2.1.2 Alginate Dressing
-
2.1.3 Skin Substitutes
-
2.1.4 Other Products
-
-
2.2 By Application
-
2.2.1 Wounds
-
2.2.2 Burns
-
2.2.3 Ulcers
-
2.2.4 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Biomaterial Wound Dressing Market Size FAQs
What is the current Biomaterial Wound Dressing Market size?
The Biomaterial Wound Dressing Market is projected to register a CAGR of 11.20% during the forecast period (2024-2029)
Who are the key players in Biomaterial Wound Dressing Market?
ConvaTec Group PLC, Smith & Nephew PLC, Mölnlycke Health Care AB, B. Braun Melsungen AG and 3M are the major companies operating in the Biomaterial Wound Dressing Market.
